one8zero8 LLC Invests $1.54 Million in Waters Co. (NYSE:WAT)

one8zero8 LLC acquired a new stake in shares of Waters Co. (NYSE:WAT - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 4,150 shares of the medical instruments supplier's stock, valued at approximately $1,540,000.

Several other large investors have also recently added to or reduced their stakes in the stock. Advisory Alpha LLC increased its stake in shares of Waters by 2.6% in the fourth quarter. Advisory Alpha LLC now owns 1,065 shares of the medical instruments supplier's stock worth $395,000 after acquiring an additional 27 shares during the last quarter. Summit Trail Advisors LLC raised its stake in shares of Waters by 2.4% during the 3rd quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier's stock worth $431,000 after purchasing an additional 28 shares in the last quarter. Empowered Funds LLC raised its stake in shares of Waters by 3.0% during the 4th quarter. Empowered Funds LLC now owns 966 shares of the medical instruments supplier's stock worth $358,000 after purchasing an additional 28 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. grew its stake in shares of Waters by 0.3% in the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 9,610 shares of the medical instruments supplier's stock valued at $3,565,000 after buying an additional 30 shares in the last quarter. Finally, OneDigital Investment Advisors LLC increased its holdings in Waters by 3.8% in the third quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier's stock worth $306,000 after buying an additional 31 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company's stock.

Remove Ads

Waters Stock Performance

Waters stock traded up $1.49 on Tuesday, hitting $380.41. The company's stock had a trading volume of 307,183 shares, compared to its average volume of 472,741. The company has a fifty day moving average price of $391.26 and a 200-day moving average price of $370.72. The firm has a market cap of $22.60 billion, a P/E ratio of 35.52, a price-to-earnings-growth ratio of 3.79 and a beta of 1.00. Waters Co. has a one year low of $279.24 and a one year high of $423.56. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. On average, equities analysts anticipate that Waters Co. will post 12.86 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have commented on WAT shares. Sanford C. Bernstein raised shares of Waters from a "market perform" rating to an "outperform" rating and set a $430.00 target price for the company in a research report on Friday, January 10th. StockNews.com downgraded Waters from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Bank of America lowered their price target on Waters from $430.00 to $410.00 and set a "neutral" rating on the stock in a report on Thursday, February 13th. JPMorgan Chase & Co. boosted their price objective on shares of Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a research note on Thursday, March 6th. Finally, UBS Group boosted their target price on shares of Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a research report on Thursday, February 13th. Eleven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $391.07.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.